News

Constant Contribution to Science

We are excited to share that our Head of Biostatistics, Prof. Krassimir Kalinov, has recently contributed as an author to several new publications, including:

    •    COVID-19 Infection in Chronic Kidney Disease Patients: Risk Factors for Death and Acute Kidney Injury – https://pubmed.ncbi.nlm.nih.gov/36294815/
    •    Serum and Urinary Biomarkers in COVID-19 Patients with or without Baseline Chronic Kidney Disease – https://pubmed.ncbi.nlm.nih.gov/36983566/
    •    Renin-angiotensin-aldosterone system blockers in COVID-19 patients with or without chronic kidney disease – https://pubmed.ncbi.nlm.nih.gov/36482641/
    •    Assessment of extrafine beclomethasone/formoterol for the treatment of chronic obstructive pulmonary disease: A non-interventional study in a Bulgarian population – https://pubmed.ncbi.nlm.nih.gov/36252915/

We are confident that Prof. Kalinov’s contributions will further enhance the scientific community’s understanding of different diseases and the application of Biostatistics in real-world settings.

As an organization committed to science, Comac Medical continues to support scientific activities through our daily activities and not only.

Share:
Comac Medical is proud to announce the appointment of Peter Windisch as its new Chief Operations Officer (COO).
For small to mid-sized biotech companies, navigating the complexities of clinical trials can be challenging. With limited resources,...
Sofia, November 15th 2024 – Comac Medical is proud to announce the launch of new sustainability initiatives aimed...